title: Fatal cardiovascular complication 19 years after treatment for fibrosarcoma.
authors.affiliation: University College London.
authors.forename: M
authors.initials: M
authors.lastname: Galloway
authors.forename: D
authors.initials: D
authors.lastname: MacLeod
authors.forename: M
authors.initials: M
authors.lastname: Sheaff
authors.forename: J
authors.initials: J
authors.lastname: Wedzicha
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001859:Bone Neoplasms / Q000628:therapy*; D017024:Chemotherapy, Adjuvant / Q000009:adverse effects; D004317:Doxorubicin / Q000009:adverse effects*; D004719:Endomyocardial Fibrosis / Q000209:etiology*; D017809:Fatal Outcome; D005354:Fibrosarcoma / Q000628:therapy*; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000009:adverse effects; D011878:Radiotherapy / Q000009:adverse effects; D014750:Vincristine / Q000009:adverse effects
chemical_list: D000970:Antineoplastic Agents; D014750:Vincristine; D004317:Doxorubicin; D008727:Methotrexate